Banks ML,Worst TJ,Rusyniak DE,Sprague JE .2014 .Synthetic cathinones ("bath salts"). J Emerg Med, 46(5) : 632-42.
Maxwell JC,Rutkowski BA .2008 .The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators,. Drug Alcohol Rev, 27(3) : 229-35.
Bramness JG,Gundersen ØH,Guterstam J,Rognli EB,Konstenius M,Løberg EM .2012 .Amphetamine-induced psychosis-a separate diagnostic entity or primary psychosis triggered in the vulnerable. BMC Psychiatry, 12 : 221.
Tost H,Alam T,Meyer-Lindenberg A .2010 .Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev, 34(5) : 689-700.
McKetin R,Leung J,Stockings E,Huo Y,Foulds J,Lappin JM .2019 .Mental health outcomes associated with amphetamine use: a systematic review and meta-analysis. EClinicalMedicine, 16 : 81-97.
Berman S,O'Neill J,Fears S,Bartzokis G .2008 .Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci, 1141 : 195-220.
Mullen JM,Richards JR,Crawford AT . .Amphetamine-related psychiatric disorders [Internet]. updated 2023 Jun 8; cited 2025 Jan, 24 : Jan.
Degenhardt L,Roxburgh A,Black E,Bruno R,Campbell G,Kinner S .2008 .The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev, 27(3) : 243-52.
Fusar-Poli P,Estradé A,Stanghellini G,Venables J,Onwumere J,Messas G .2022 .The lived experience of psychosis: a bottom-up review co-written by experts by experience and academics. World Psychiatry, 21(2) : 168-88.
Iqbal MN,Levin CJ,Levin FR .2019 .Treatment for substance use disorder with co-occurring mental illness. Focus (Am Psychiatr Publ), 17(2) : 88-97.
Ferrucci M,Limanaqi F,Ryskalin L,Biagioni F,Busceti CL,Fornai F. .2019 .The effects of amphetamine and methamphetamine on the release of norepinephrine, dopamine, and acetylcholine from the brainstem reticular formation. Front Neuroanat, 13 : 48.
McCutcheon RA,Krystal JH,Howes OD .2020 .Dopamine and glutamate in schizophrenia: biology, symptoms, and treatment. World Psychiatry, 19(1) : 15-33.
Glasner-Edwards S,Mooney LJ .2014 .Methamphetamine psychosis: epidemiology and management. CNS Drugs, 28(12) : 1115-26.
Ali MI,Rashad MM,Alzain NM,Al-Awad FA,Alzaharani MA,Alshamarani AS .2024 .Impulsiveness, suicide, and aggression in a sample of patients with disorders of methyl amphetamine use. J Family Community Med, 31(3) : 257-64.
Luo D,Tan L,Shen D,Gao Z,Yu L,Lai M .2022 .Characteristics of depression, anxiety, impulsivity, and aggression among various types of drug users and factors for developing severe depression: a cross-sectional study. BMC Psychiatry, 22(1) : 274.
Kelly TM,Daley DC .2013 .Integrated treatment of substance use and psychiatric disorders. Soc Work Public Health, 28(3-4) : 388-406.
Quello SB,Brady KT,Sonne SC .2005 .Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect, 3(1) : 13-21.
Davis LL,Frazier E,Husain MM,Warden D,Trivedi M,Fava M .2006 .Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR∗D cohort. Am J Addict, 15(4) : 278-85.
Zarrabi H,Khalkhali M,Hamidi A,Ahmadi R,Zavarmousavi M. .2016 .Clinical features, course, and treatment of methamphetamineinduced psychosis in psychiatric inpatients. BMC Psychiatry, 16 : 44.
Lecomte T,Mueser KT,MacEwan W,Thornton AE,Buchanan T,Bouchard V .2013 .Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment. J Nerv Ment Dis, 201(12) : 1085-9.
Fluyau D,Mitra P,Lorthe K. .2019 .Antipsychotics for amphetamine psychosis: a systematic review. Front Psychiatry, 10 : 740.